Search

Author/Creator Dietmaier, W

1. 1O Harmonization and standardization of panel-based tumour mutational burden (TMB) measurement: Real-world results and recommendations of the QuIP study. (15th December 2019)

Authors:
Stenzinger, A; Endris, V; Budczies, J; Merkelbach-Bruse, S; Dietmaier, W; Siebolts, U; Maas, J; Merino, D M; Stewart, M; Allen, J; Glimm, H; Thiemann, M; Aust, D; Hummel, M; Moch, H; Jung, A; Haller, F; Weichert, W; Dietel, M
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 11
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 35PDetection of ALK, RET, ROS1, NTRK1 and MET rearrangements and actionable mutations using next generation sequencing in patients with non-small cell lung cancer. (16th September 2018)

Authors:
Harlé, A; Dietmaier, W; Vogl, I; Neumann, K; Haumaier, F; Beggs, A D; Pestinger, V; Grand, D; Tallet, A; Merlin, J-L
Journal:
Annals of oncology
Issue:
Volume 29:Number 6(2018)Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Low-grade abdominopelvic sarcoma with myofibroblastic features (low-grade myofibroblastic sarcoma): clinicopathological, immunohistochemical, molecular genetic and ultrastructural study of two cases with literature review. Issue 3 (18th May 2007)

Authors:
Agaimy, A; Wünsch, P H; Schroeder, J; Gaumann, A; Dietmaier, W; Hartmann, A; Hofstaedter, F; Mentzel, T
Journal:
Journal of clinical pathology
Issue:
Volume 61:Issue 3(2008)
Page Start:
301
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗